OMER
OMER
NASDAQ · Pharmaceuticals

Omeros Corp

$12.56
+0.00 (+0.00%)
As of Aug 8, 1:47 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +418.9% upside
Low Target $47.12
Average Target $65.17
High Target $100.64
Current Price $12.56
Current
$12.56
Target
$65.17
$47.12 $65.17 avg $100.64
Scenario Analysis
Bear Case
$47.12
275.2%
Low target
Base Case
$65.17
+418.9%
Avg target
Bull Case
$100.64
+701.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$17.65
-28.8% from high
52-Week Low
$3.70
+239.5% from low
Target vs 52W High
$65.17
+269.2% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.27
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%